Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-23-058082

See Remarks acquired 14,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Rhode Peter See Remarks 2023-12-11 Option exercise +14,000 $0.14 $1,960 77,500 D
Derivatives
Rhode Peter See Remarks 2023-12-11 Option exercise · Stock Option (Right to Buy) −14,000 22,427 D
Loading xslF345X05/doc4.xml…